In the News
How A.I. Is Finding New Cures in Old Drugs
GNS CEO and Co-Founder Colin Hill is shares his thoughts on the stat of AI and biopharma with Fortune reporter Tiernan Ray. Read the full article here.
read more
GNS Co-Founder Iya Khalil Named to Forbes list of “50 Women-Led Startups That Are Crushing Tech”
GNS Co-Founder Iya Khalil joins 49 other female entrepreneurs who are pushing the frontiers of innovation across various industries. Read the full...
read more
GNS Co-Founder and CEO Colin Hill Discusses how AI will Power the Future of in silico Clinical Trials
GNS Co-Founder and CEO Colin Hill sat down with Outsourcing Pharma's Melissa Fassbender to discuss how in silico are making personalized medicine a reality. The interview covered how technology is driving pharma efforts to transition from resource-intensive trials to...
read moreEvents
Colin Hill Talks Health Data Privacy at Fortune Brainstorm Health Copy
Colin Hill, GNS Healthcare's Chairman, CEO, and Co-founder, will be featured on the panel "The End of Heath Care Privacy... And is it a Good Thing?" at the Fortune Brainstorm Health Conference on Tuesday, March 20th. As health care data continues to grow...
read more
Colin Hill Moderates Panel on AI at Forbes Healthcare Summit
Colin Hill, GNS CEO and co-founder moderated panel at The Forbes Healthcare Summit, held November 29th. The panel, “How Smart Is Artificial Intelligence?” brought together industry leaders to discuss the potential of AI to change healthcare. Panelists included...
read more
Colin Hill featured on AI panel at 2018 Personalized Medicine Conference
Colin Hill, CEO and co-founder of GNS Healthcare participated on a panel at the 14th Annual Personalized Medicine Conference, held Wednesday, November 14th. The panel, “Automating Actionable: How Artificial Intelligence is Charting a Course for Personalized Medicine...
read morePress Releases
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreGNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read more